MedPath
HSA Approval

BEAFLU PLUS TABLET

SIN11457P

BEAFLU PLUS TABLET

BEAFLU PLUS TABLET

February 23, 2001

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N02BE51

paracetamol, combinations excl. psycholeptics

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

PARACETAMOL

500 mg

Acetaminophen

PSEUDOEPHEDRINE HCl

30 mg

Pseudoephedrine

CHLORPHENIRAMINE MALEATE

2 mg

Chlorpheniramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEAFLU PLUS TABLET - HSA Approval | MedPath